@_25m9: #عيد #ميلادي #سبتمبر_♡ #ايلول

shahad🫧

Open In TikTok:

Region: IQ

Monday 02 September 2024 18:53:39 GMT

912740

17349

439

4443

Music

Download

No Watermark .mp4 (0.5MB) No Watermark(HD) .mp4 (0.42MB) Watermark .mp4 (0MB) Music .mp3

Comments

𝒎𝒂𝒓𝒊𝒂𝒎/الكعبي :

يأبه دخلت اني ٢٠٠٣ يوم ٧ بهذا الشهر ادخل سنه جديده شصير ٢٢ لو ٢٣🗿

2024-09-03 14:20:18

13

ام علي البصراويه :

كل عام وانتي بالف خير بنت عمي

2024-10-02 09:22:57

0

فِٰ͒ـۛৣـرآ🦋شِٰـۛৣـ໋۠هہ :

يوم عيد ميلادي وزوجي سوه عزيمه الصدقاءه واني ٧ ساعات بالمطبخ خوش عيد ميلاد هذا 😭😭😭😂💔

2024-09-03 11:11:53

8

𝘼𝙨𝙤𝙪𝙡𝙖˚ 🦢 :

كل عام وانتي بالف خير حبيبتي 🥹🫀

2024-09-02 20:40:45

0

𝐅𝐚𝐭𝐢𝐦𝐚 𝐇𝐮𝐬𝐬𝐞𝐢𝐧 :

كلولي شلونها ٢٣اتحمسلها لو نفس وضع 🥲

2024-09-03 11:29:19

2

اغاتـ,ٰٓهـٰـن🐆 :

كل عام وانتي بالف صحة وعافية يارب بنت عمي 🥰

2024-09-03 10:41:29

0

عــــــــآصـــفــــــهِ💨 :

يوم عيد ميلادي ومحد مذكرا🥺✨

2024-10-01 13:58:08

7

ࢪُبَما 𝑹 :

يوم 28 يصير عمري 24 😔🤏🫂কারণ আমিফেরত

2024-09-03 17:25:08

3

تـقـئ𐙚 :

زبط بط صرت 24 🤦‍♀️🙇‍♀️💔

2024-09-03 18:00:05

2

ماެري™ :

لعد اني فهمت وصلت24

2024-09-03 16:53:15

1

hana :

اي ونبي صدك زط بط لني ٢١💔🥲

2024-09-03 14:32:04

1

ست رؤى :

١٩٩٨ صارو ٢٦ كلشي ما فهمنا😭

2024-09-03 15:23:45

1

2001_TM3 :

يي والله 😭😭

2024-09-06 10:55:15

1

زهرة ابيها 🥀 :

😂😂😂😂 انة مثلج قبل 3 اشهر صرت 23

2024-09-03 15:15:00

1

◜𝘡𝒂𝒊𝒏𝒂𝒃 :

زط بط صرت25 😂

2024-09-03 14:37:02

1

ريحــانــة مـْحـًمــْد🦋 :

زط بط 25 سنة🥹😂

2024-09-03 20:51:38

1

🌹Fatima 🌹 :

اي والله السنين تركض ركض 🥺

2024-09-05 02:16:30

1

❤️ ان الله معنا ❤️ :

اي والله صدك زط بط صرنه ٢٨🤔😔

2024-09-03 12:55:01

1

/flora/فلورا /أليسر 🪽 :

صرت 27 شلون ماادري وباقي 3اشهر واصير 28 🌚

2024-09-03 19:42:37

3

أم التوائم 💙👩‍👧‍👧🧿🪐 :

ايي والله زط بط صرنه 23😔😭😂

2024-09-03 15:19:46

1

❤❤ :

يامواليد انتي

2024-10-01 15:42:12

1

هبة البدري 🩵. :

حبيبتي كل عام وأنتي بخير ❤️بگدي أنتي أني مسويت شي لأن كل سنة يصادف بمحرم😂

2024-09-03 10:08:07

1

ـوࢪدً ✿ :

يي والله كلشي ما فتهمنه بعد اسبوع عيد ميلادي🥲

2024-09-03 18:55:23

3

To see more videos from user @_25m9, please go to the Tikwm homepage.

Other Videos

K.Maraş Ömür Paça Kebapta Fatih Şefimden Pilav Yanında Püreli Köfte Servisi…😎😎 #türkiye #kahramanmaraş #yemek #gurmemarask

K.Maraş Ömür Paça Kebapta Fatih Şefimden Pilav Yanında Püreli Köfte Servisi…😎😎 #türkiye #kahramanmaraş #yemek #gurmemarask

Bikin merinding banget! 🥶 Totalitas akting Arya Saloka di adegan ini benar-benar juara dan sukses bikin kita ikut merasakan tegangnya. Akting yang luar biasa dan totalitas tanpa batas! Menurut kalian, siapa nih yang paling gak sabar buat nonton akting keren mereka di layar lebar? Tulis di komentar ya! 👇 Siap-siap uji nyali di bioskop tanggal 3 September 2026! #FilmMunafik #MunafikMelawanIblis #MunafiknyaIndo #BahayaJadiMunafik #cpfMMI @unlimited_production

Bikin merinding banget! 🥶 Totalitas akting Arya Saloka di adegan ini benar-benar juara dan sukses bikin kita ikut merasakan tegangnya. Akting yang luar biasa dan totalitas tanpa batas! Menurut kalian, siapa nih yang paling gak sabar buat nonton akting keren mereka di layar lebar? Tulis di komentar ya! 👇 Siap-siap uji nyali di bioskop tanggal 3 September 2026! #FilmMunafik #MunafikMelawanIblis #MunafiknyaIndo #BahayaJadiMunafik #cpfMMI @unlimited_production

Rumah yang luarnya gak keliatan mewah, tapi pas begitu masuk mewah banget, kok bisa? @serba_collection08 #design #clippers #wefluence r3sctjj8

Rumah yang luarnya gak keliatan mewah, tapi pas begitu masuk mewah banget, kok bisa? @serba_collection08 #design #clippers #wefluence r3sctjj8

Are GLP-1 receptor agonists (like semaglutide and tirzepatide) doing more than just driving weight loss and glycemic control? Emerging observational studies and clinical trials suggest they may reduce the incidence of obesity-associated cancers and improve overall survival in active cancer patients! Let's break down the scientific mechanisms: 🩺🫁👇

Hi, I'm Dr. Cleo Riles, Harvard-trained cancer researcher and science communicator. Welcome to Part 1 of my ongoing GLP-1s & Cancer Research Series:

🧬 1. THE METABOLIC & TUMOR INTERSECTION:

13 Obesity-Associated Cancers: Obesity drives chronic low-grade inflammation, hyperinsulinemia, elevated IGF-1 (insulin-like growth factor 1), and altered adipokines (leptin/adiponectin ratio)—all of which promote tumor cell proliferation and angiogenesis.

Direct vs. Indirect Pathways: GLP-1s lower cancer risk indirectly through substantial adiposity loss and improved insulin sensitivity. However, researchers are also investigating direct GLP-1 receptor signalling in immune cells (e.g., NK cell restoration) and tumor microenvironments.

📊 2. WHAT THE EARLY SIGNALS SHOW:

Incidence Reduction: Large retrospective cohort studies show significant risk reductions in colorectal, pancreatic, endometrial, ovarian, and breast cancers compared to traditional anti-diabetic medications like insulin or sulfonylureas.

Active Cancer Outcomes: Emerging studies are evaluating whether GLP-1 use during or after active treatment improves recurrence-free survival (RFS) and treatment response (e.g., reversing chemotherapy resistance driven by metabolic dysfunction).

🔬 3. WHAT TO WATCH FOR IN THIS SERIES:
Over the next several weeks, I'll be breaking down landmark studies, real-world comparative effectiveness data, and my own upcoming research presentation on GLP-1 use and breast cancer outcomes!

👇 What questions do you have about GLP-1 medications and cancer risks? Leave them below!
#GLP1 #Oncology #CancerResearch #Ozempic #Wegovy

Are GLP-1 receptor agonists (like semaglutide and tirzepatide) doing more than just driving weight loss and glycemic control? Emerging observational studies and clinical trials suggest they may reduce the incidence of obesity-associated cancers and improve overall survival in active cancer patients! Let's break down the scientific mechanisms: 🩺🫁👇 Hi, I'm Dr. Cleo Riles, Harvard-trained cancer researcher and science communicator. Welcome to Part 1 of my ongoing GLP-1s & Cancer Research Series: 🧬 1. THE METABOLIC & TUMOR INTERSECTION: 13 Obesity-Associated Cancers: Obesity drives chronic low-grade inflammation, hyperinsulinemia, elevated IGF-1 (insulin-like growth factor 1), and altered adipokines (leptin/adiponectin ratio)—all of which promote tumor cell proliferation and angiogenesis. Direct vs. Indirect Pathways: GLP-1s lower cancer risk indirectly through substantial adiposity loss and improved insulin sensitivity. However, researchers are also investigating direct GLP-1 receptor signalling in immune cells (e.g., NK cell restoration) and tumor microenvironments. 📊 2. WHAT THE EARLY SIGNALS SHOW: Incidence Reduction: Large retrospective cohort studies show significant risk reductions in colorectal, pancreatic, endometrial, ovarian, and breast cancers compared to traditional anti-diabetic medications like insulin or sulfonylureas. Active Cancer Outcomes: Emerging studies are evaluating whether GLP-1 use during or after active treatment improves recurrence-free survival (RFS) and treatment response (e.g., reversing chemotherapy resistance driven by metabolic dysfunction). 🔬 3. WHAT TO WATCH FOR IN THIS SERIES: Over the next several weeks, I'll be breaking down landmark studies, real-world comparative effectiveness data, and my own upcoming research presentation on GLP-1 use and breast cancer outcomes! 👇 What questions do you have about GLP-1 medications and cancer risks? Leave them below! #GLP1 #Oncology #CancerResearch #Ozempic #Wegovy

Lo amo con locura y espero en Dios teberlo siempre conmigo #biker #fyp #cbr600rr #moto #honda #rodar #motorcycle @Jorge Guerrero mi bito 💜

Lo amo con locura y espero en Dios teberlo siempre conmigo #biker #fyp #cbr600rr #moto #honda #rodar #motorcycle @Jorge Guerrero mi bito 💜

About

Robot
API

Legal

Privacy Policy